Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Cook

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
AIDS (London, England)|April 12, 2016
Once vs twice-daily abacavir and lamivudine in African childrenVictor Musiime, Philip Kasirye, Bethany Naidoo-James, et al.
Antiviral Therapy|April 11, 2014
Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trialVictor Musiime, Adrian Cook, Joshua Kayiwa, et al.
The Journal of Infectious Diseases|August 15, 2018
Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIVFelicity C Fitzgerald, Edouard Lhomme, Kathryn Harris, et al.
Lancet (London, England)|October 1, 2020
Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate dataClaire L Vale, David Fisher, Andrew Kneebone, et al.
JAMA Oncology|February 18, 2021
Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical TrialAdnan Ali, Alex Hoyle, Áine M Haran, et al.
European Journal of Cancer (Oxford, England : 1990)|August 5, 2023
Survival and modelled cancer antigen-125 ELIMination rate constant K score in ovarian cancer patients in first-line before poly(ADP-ribose) polymerase inhibitor era: A Gynaecologic Cancer Intergroup meta-analysisPauline Corbaux, Benoit You, Rosalind M Glasspool, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 19, 2025
Identifying high-risk relapse in early-stage I to II ovarian cancer using the CA125 ELIMination rate constant K (KELIM) score: a Gynecologic Cancer InterGroup individual patient-data meta-analysisPauline Corbaux, Benoit You, Tatsuo Kagimura, et al.
JAMA Network Open|January 11, 2020
Assessment of Progression-Free Survival as a Surrogate End Point of Overall Survival in First-Line Treatment of Ovarian Cancer: A Systematic Review and Meta-analysisXavier Paoletti, Liz-Anne Lewsley, Gennaro Daniele, et al.
British Journal of Cancer|April 1, 2022
Low probability of disease cure in advanced ovarian carcinomas before the PARP inhibitor eraBenoit You, Lilian Van Wagensveld, Michel Tod, et al.
Lancet (London, England)|March 31, 2016
Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trialJonathan A Ledermann, Andrew C Embleton, Fharat Raja, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
AIDS (London, England)|April 12, 2016
Once vs twice-daily abacavir and lamivudine in African childrenVictor Musiime, Philip Kasirye, Bethany Naidoo-James, et al.
Antiviral Therapy|April 11, 2014
Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trialVictor Musiime, Adrian Cook, Joshua Kayiwa, et al.
The Journal of Infectious Diseases|August 15, 2018
Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIVFelicity C Fitzgerald, Edouard Lhomme, Kathryn Harris, et al.
Lancet (London, England)|October 1, 2020
Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate dataClaire L Vale, David Fisher, Andrew Kneebone, et al.
JAMA Oncology|February 18, 2021
Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical TrialAdnan Ali, Alex Hoyle, Áine M Haran, et al.
European Journal of Cancer (Oxford, England : 1990)|August 5, 2023
Survival and modelled cancer antigen-125 ELIMination rate constant K score in ovarian cancer patients in first-line before poly(ADP-ribose) polymerase inhibitor era: A Gynaecologic Cancer Intergroup meta-analysisPauline Corbaux, Benoit You, Rosalind M Glasspool, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 19, 2025
Identifying high-risk relapse in early-stage I to II ovarian cancer using the CA125 ELIMination rate constant K (KELIM) score: a Gynecologic Cancer InterGroup individual patient-data meta-analysisPauline Corbaux, Benoit You, Tatsuo Kagimura, et al.
JAMA Network Open|January 11, 2020
Assessment of Progression-Free Survival as a Surrogate End Point of Overall Survival in First-Line Treatment of Ovarian Cancer: A Systematic Review and Meta-analysisXavier Paoletti, Liz-Anne Lewsley, Gennaro Daniele, et al.
British Journal of Cancer|April 1, 2022
Low probability of disease cure in advanced ovarian carcinomas before the PARP inhibitor eraBenoit You, Lilian Van Wagensveld, Michel Tod, et al.
Lancet (London, England)|March 31, 2016
Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trialJonathan A Ledermann, Andrew C Embleton, Fharat Raja, et al.
Pageof 6